Reckitt considers pharma future

Press Association
Vanish
Vanish

Bang to Vanish group Reckitt Benckiser is putting its pharmaceutical business under review in a move that could see the division offered for sale with a multi-billion pound price tag.

Slough-based Reckitt said it was considering "all options" for the drugs business, which is valued by some analysts at more than £2.5 billion.
%VIRTUAL-SkimlinksPromo%